Alexander Drilon MD @alexdrilon
Chief, Early Drug Development Service; Associate Attending Physician, Thoracic Oncology Service; Memorial Sloan Kettering Cancer Center mskcc.org/cancer-care/do… New York Joined October 2011-
Tweets171
-
Followers4K
-
Following214
-
Likes906
In the era of Project Optimus, expeditiousness needs to be preserved for dose finding in rare cancers. Common cancers now contain multiple rare genomic and proteomic subsets, underscoring the importance of this mindset. @YoninaMG @AlexiaIasonos
In the era of Project Optimus, expeditiousness needs to be preserved for dose finding in rare cancers. Common cancers now contain multiple rare genomic and proteomic subsets, underscoring the importance of this mindset. @YoninaMG @AlexiaIasonos
Repotrectinib is FDA approved for ROS1+ lung cancers in the TKI naive and pretreated settings. Many thanks to the patients, advocates, and study teams around the world who made this possible. onclive.com/view/fda-appro…
Two research technician positions are immediately available in my lab @HopkinsMedicine @hopkinskimmel. You will be working on KRAS targeting in solid cancer. If interested, please apply here: jobs.jhu.edu/job/Baltimore-… jobs.jhu.edu/job/Baltimore-…
Don’t miss out on the opportunity to join the lab of the fabulous Dr. Misale. Our phase I team is absolutely excited to continue working with her. Congratulations @Sandra_Misale!!
Don’t miss out on the opportunity to join the lab of the fabulous Dr. Misale. Our phase I team is absolutely excited to continue working with her. Congratulations @Sandra_Misale!!
Breaking tradition can improve patient outcomes. In novel-known combinations where the novel drug is unlikely to work well alone, prolonged exposure to monotherapy in dose escalation is not patient-centric. This alternative FDA-approved phase I design poses a potential solution.
Breaking tradition can improve patient outcomes. In novel-known combinations where the novel drug is unlikely to work well alone, prolonged exposure to monotherapy in dose escalation is not patient-centric. This alternative FDA-approved phase I design poses a potential solution. https://t.co/OslOEElw4Z
Out today in @CD_AACR our new work where we describe the genetic bases of acquired resistance to EGFR/KRAS G12C dual blockade in colorectal cancer. Here’s the link of the paper shorturl.at/EOPT8 and a thread👇:
Hello, 3rd ed! The print version is out in a few weeks. The digital version is available now on Kindle and other e-readers. Congratulations to @NouraChoudhury @YoninaMG @NeilVasan and the many contributing authors!! amazon.com/gp/aw/d/B0B9T5…
Aaaaand we're back!! 9 years really flew by since I was last here while working at #MSKCC; now as a #HOfellow @ClevelandClinic. Especially humbled to reconnect with a close friend and AMAZING mentor @alexdrilon at #ASCO22!!
Excellent work from the Klebanoff lab on TCR development for an HLA-A*03:01 restricted public neoantigen generated in the context of a PIK3CA H1047L catalytic subunit hotspot mutation. rdcu.be/cMjvb
Excellent work from the Klebanoff lab on TCR development for an HLA-A*03:01 restricted public neoantigen generated in the context of a PIK3CA H1047L catalytic subunit hotspot mutation. rdcu.be/cMjvb
RETi resistance in lung, thyroid & other cancers can be complex. This paper includes insights into the serial kinetics of resistance acquisition, the potential emergence of RET wild type populations & the frequency of polyclonal resistance. Proud to be part of this team!
The first publication of larotrectinib in NTRK fusion+ lung cancers alone is out. Beyond the initial systemic & intracranial response gains, the ~35 month median PFS and the ~41 month median OS impress. Wonderful news for patients, advocates, and providers across the world.
The first publication of larotrectinib in NTRK fusion+ lung cancers alone is out. Beyond the initial systemic & intracranial response gains, the ~35 month median PFS and the ~41 month median OS impress. Wonderful news for patients, advocates, and providers across the world.
Quick recap of today's presentation of Zeno in heavily pretreated NRG1+ solid tumors. Efficacy observed across tumor types with ORR of 42% in PDAC. Thanks to @ASCO for the opportunity to present, @GarridoLagunaMD for an excellent discussion, collaborators, and patients. #ASCO2021
I’m honored to be among the #ConquerCancer Grant & Award Class of 2021 (CDA) and 2018 (YIA). Donors make these research opportunities possible. Give to the @ASCO CONQUERS CANCER Fund to help fuel the next generation of researchers bit.ly/ASCOCONQUERSCA… #ASCO21
I’m honored to be among the #ConquerCancer Grant & Award Class of 2021 (CDA) and 2018 (YIA). Donors make these research opportunities possible. Give to the @ASCO CONQUERS CANCER Fund to help fuel the next generation of researchers bit.ly/ASCOCONQUERSCA… #ASCO21
Congratulations to @NouraChoudhury on her @ConquerCancerFd @ASCO Young Investigator Award. I'm lucky to co-mentor her with @HelenaYu923 . She has an interesting trial combining amivantamab and lazertinib in patients with EGFR mutant NSCLC progressing in the CNS (almost open!).
RETpositive has officially launched! We are a patient-led coalition formed to advance research on RET+ cancers. Through our partnership with @LUNGevity and a generous donation-matching program, we hope to fund lifesaving research. Join us at retpositive.org #RETcancer
Repotrectinib gets Breakthrough Therapy Designation by the US FDA for TKI-naïve ROS1 fusion-positive lung cancers. Congratulations to the TRIDENT-1 investigators and patients. google.com/amp/s/finance.…
MET IHC is back from the dead! We wrote it off as a biomarker, but pl see latest study from our group lead by @alexdrilon & @RobinGuo5 which found MET expression to predict TKI response in MET Ex 14-altered NSCLC. Twists & turns of the ever-evolving NSCLC biomarker story!
A call for rational type II TKI development. Seen through the lens of next-gen TRK inhibitor resistance in TRK fusion+ cancers. 🤓Highlights the utility of TKI type switching as a strategy for on-target resistance in oncogene-driven tumors. @EmilianoCocco2 @ScaltritiLab
A call for rational type II TKI development. Seen through the lens of next-gen TRK inhibitor resistance in TRK fusion+ cancers. 🤓Highlights the utility of TKI type switching as a strategy for on-target resistance in oncogene-driven tumors. @EmilianoCocco2 @ScaltritiLab
Wonderful team effort from many people around the world. I want to take a second to especially thank our patients and families without whom we could not have accomplished this. We are in your debt. Shout out to the RET Renegades! nejm.org/doi/full/10.10…
Excited to chair a free online lung cancer @OncLive webinar with @benlevylungdoc covering the latest topics in management of #NSCLC Wednesday, October 14, 6:30pm EST featuring expert faculty: @alexdrilon @IbiayiMD @Joshua_Reuss @kamarrone #LCSM event.onclive.com/d/q7qppz
Stephen V Liu, MD @StephenVLiu
28K Followers 3K Following Thoracic Oncologist, Chief of Heme/Onc @Georgetown University; Head of Developmental Therapeutics @LombardiCancer; Co-Chair #DCLung26 & #TexasLung26; #HereWeGo
Vivek Subbiah, MD @VivekSubbiah
39K Followers 2K Following Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Jarushka Naidoo @DrJNaidoo
11K Followers 1K Following Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins University
Paolo Tarantino @PTarantinoMD
29K Followers 700 Following MD, PhD, Medical Oncologist | Clinical Fellow @DanaFarber | @Harvard. Associate Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs and good music.
d.planchard @dplanchard
6K Followers 213 Following Thoracic Oncologist - Prof at University Paris Saclay - Head of Thoracic Group, Medical Oncology Dpt- Gustave Roussy - Villejuif - France 🇫🇷 and INSERM U981
H. Jack West, MD, FAS... @JackWestMD
22K Followers 3K Following VP of Clin Development, Therapeutic Area Head, Thoracic Onc @SMMT_Tx; Founder,@CancerGRACE; fmr author/ed @UptoDate; Likes/RTs ≠ endorsement
FabriceAndre @FAndreMD
15K Followers 503 Following Head of Research Division of @GustaveRoussy , @myesmo President Elect
Christine Lovly, MD, ... @christine_lovly
8K Followers 886 Following Thoracic Medical Oncologist & Physician Scientist @VUMC. Member @AACR Board of Directors. Dog lover. Believer that kindness counts. Views = my own. @Oncoalert
Lecia Sequist, MD, MP... @LeciaSequist
10K Followers 2K Following Program Director, Cancer Early Detection & Diagnostics @MassGenBrigham @AmLungCSI #Equity #NoOneDeservesLungCancer #ScreeningSavesLives @IASLC She/her
OncLive.com @OncLive
48K Followers 2K Following Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
ESMO - Eur. Oncology @myESMO
80K Followers 974 Following The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
Patrick Forde @FordePatrick
7K Followers 2K Following Lung cancer & Mesothelioma. Immunotherapy believer. 🇮🇪 🇺🇸
Jill Feldman @jillfeldman4
9K Followers 4K Following Lung Cancer Patient and Advocate, Co-Founder @EGFRResisters, wife, mom of 4, #LCSM #LungCancer #EndStigma #StandUpToJewishHate #RockChalk
soria @jsoriamd
17K Followers 210 Following SVP Oncology Global Development @Amgen, Physician-Scientist, Medical Oncologist, immune and molecular target-believer, Tweets my own
Ivy Elkins @ivybelkins
5K Followers 3K Following Co-Founder, @EGFRResisters LC Patient Group; writer for https://t.co/W6HLnN0ibZ; lc advocate/survivor; dx stage IV 2013, @Princeton & @Wharton alum.
Jordi Remon @JordiRemon
4K Followers 96 Following Medical Oncologist - Thoracic tumors. Personalized treatment approches, Chair Lung Cancer Group @EORTC,
Cancer Discovery @CD_AACR
22K Followers 230 Following Follow Cancer Discovery for high-impact articles and news covering major advances in basic, translational, and clinical cancer research. Published by @AACR.
Andres F. Cardona @AndresFCardonaZ
9K Followers 4K Following Pursue knowledge, mentor students, collaborate globally, and push boundaries. Everything else is just noise in the academic concert.
IASLC @IASLC
21K Followers 2K Following The International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer. #LCSM
Rita Leporati @Ritalepp
581 Followers 562 Following Medical Oncologist | Research Fellow @UNIMORE_univ | trained @IstTumori | #lungcancer
Simon Mayr @simonmayr
139 Followers 449 Following As COO at MD Education, I am leading efforts to redefine medical education by collaborating with the world's most renowned medical doctors.
HemOncBytes @HemOncBytes
414 Followers 5K Following Your Antidote to the Oncology Information Flood | Bite-Sized Learning, Built for Busy Schedules. 🔥Largest Hem/Onc Qbank in existence!! #MedTwitter #HemeOnc.
Evidentis™ Clinical... @EvidentisHQ
350 Followers 5K Following Advancing liver & metabolic health through our own Phase 1–4 clinical trials, while partnering with others through collaboration & strategic partnerships.
KMCK2424 @kmck2424
356 Followers 2K Following
EmRem @EmRem42519531
1 Followers 324 Following
Kirsten Duncan, Pharm... @KirstenDun2025
11 Followers 77 Following Medical Affairs Strategy Lead #Nuvalent | Passionate about collaborating to advance lung cancer research and therapies
MedJ @MedJ0401
31 Followers 148 Following Welcome to follow "MedJ"! Based in China, we are a medical media platform dedicated to serving healthcare professionals, enhancing medical care!
Debi @d59192223315591
32 Followers 202 Following
Ben D @BenD1029
4 Followers 127 Following
Ovrufe @Ovrufe0685
66 Followers 2K Following
viktoria valera @salingpusalang
788 Followers 3K Following Perpetual traveller. Old soul. Medical oncologist by vocation 🦀
Andrew Little, Ph.D. @AndrewCLittle1
245 Followers 705 Following Husband | Dad | Son | Brother | Dog dad | Outdoorsman | Senior Medical Science Liaison Oncology at Nuvalent
Paz-Ares's Lab @PazAresLab
1K Followers 746 Following Research group @CNIOStopCancer and H12O led by @LuisPaz_Ares. Exploring new therapies for lung cancer. Tweets by Itziar Otano
Zhen Su, MD; MBA @MyOncology
655 Followers 623 Following Physician Scientist, Biotech entrepreneur, Cancer Immunologist, opinions are my own
はるたか @biotecharutaka
287 Followers 1K Following
LeoMaritimus @LeoMaritimus
38 Followers 2K Following
Diego Carrillo @dicarrillob
55 Followers 198 Following MedOnc - Thoracic and Head&Neck malignancies. Pontificia Universidad Católica de Chile.
Rem Pelli @PelliRem
0 Followers 68 Following
Vall d’Hebron Insti... @VHIO
11K Followers 1K Following Leading translational research to accelerate & advance personalized and targeted therapies against cancer. @iCERCA centre
Oncology X Miner @oncominer
7 Followers 351 Following Follow every oncology X account, that's the goal
Emy @Emy170679
1 Followers 55 Following
Irina Veytsman @IrinaVeytsman
32 Followers 27 Following Head and neck and lung cancer expert, Chief of Hem/Onc DC VA Medical Center, NCI alum.
Dan Li @DanLi153334
1 Followers 17 Following
Fabian Acker @FabianAckerMD
1 Followers 62 Following Thoracic Onologist and Molecular Tumor Board (MTB) lead. Clinical research enthusiast. Proud developer of V-Exploder (https://t.co/mPg7t1MH28)
Garima @Garima111111111
38 Followers 141 Following
Ying Long, PharmD, BC... @Ying_Long18
14 Followers 326 Following
Ebube @Ebube2376
0 Followers 3 Following
Karachi von Neumann @quartzmallard
17 Followers 231 Following
World Journal of Onco... @WJON_Journal
3K Followers 3K Following PubMed/PubMed Central/Scopus/EMbase/Web of Science (ESCI) indexed, JCR Impact Factor 2024: 3.1 Editor-in-Chief: Prof. Kazuaki Takabe, New York, USA
Journal of Clinical M... @JOCMR_journal
3K Followers 3K Following PubMed/PubMed Central/Scopus/Google Scholar/Web of Science (ESCI) indexed, JCR Impact Factor 2024: 3.2 Editor-in-Chief: Prof. Kei Nakajima, Tokyo, Japan
Martin Lehr @MLehrPHL
344 Followers 311 Following CEO at @Context_Tx, $CNTX. BoD Praesidia BioTherapeutics and @CureDuchenne. Philly biotech champion.
Kimberley @MollyDu127
285 Followers 5K Following
Long Jiang @DylanDrJiang
72 Followers 200 Following CT Surgeon | Shanghai, China | IASLC Committee Deputy Chair | ASCO IDEA & IASLC Academy/Education/Mentorship Awardee | Focused on Lung Cancer & Global Onco
Greg Stephenson @GStephenson182
66 Followers 598 Following
Aaron @AaronTeoh21
36 Followers 228 Following Nerdy oncology geek with 'Golden Retriever' energy🤓🐕 Colorectal lead with keen interest in Thoracic | UGI | HPB | clinical trials in Clatterbridge Liverpool
Javen Chang @JavenChang_X
14 Followers 106 Following
Eri @JiaBen19533
57 Followers 1K Following
James Wu | 吴简凡 ... @JamesFanWu
2K Followers 2K Following @MedicalCollege Heme/Onc Fellow & @nih_nhlbi R38 Scholar 🩺🥼 @ASH_hematology HONORS🩸@DukeU Alum 😈 Husband+Dad 👶🏻 #LCSM #HealthEquity He/Him/他. My Opinions
Julian Etessami @JD_Etessami
46 Followers 377 Following Medical Oncology Resident | European Insititute of Oncology (IEO) | UNIMI
Bar Hadad @BarHadad11
14 Followers 301 Following
DocAssistant @DocAssistant_ai
112 Followers 5K Following 💡AI medical scribe that provides evidence based clinical recommendations 🩺 Built by clinicians, for clinicians
MitoAI @Vox_MitoAI
10 Followers 728 Following AI for Life Sciences on a mission to transform stakeholder engagement and dialogue
Stephen V Liu, MD @StephenVLiu
28K Followers 3K Following Thoracic Oncologist, Chief of Heme/Onc @Georgetown University; Head of Developmental Therapeutics @LombardiCancer; Co-Chair #DCLung26 & #TexasLung26; #HereWeGo
Vivek Subbiah, MD @VivekSubbiah
39K Followers 2K Following Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
Toni Choueiri, MD @DrChoueiri
43K Followers 406 Following Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; ⚽ lover; 🚲@PanMass rider.
Jarushka Naidoo @DrJNaidoo
11K Followers 1K Following Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins University
Paolo Tarantino @PTarantinoMD
29K Followers 700 Following MD, PhD, Medical Oncologist | Clinical Fellow @DanaFarber | @Harvard. Associate Editor @ESMO_Open. Interested in breast oncology, HER2, ADCs and good music.
d.planchard @dplanchard
6K Followers 213 Following Thoracic Oncologist - Prof at University Paris Saclay - Head of Thoracic Group, Medical Oncology Dpt- Gustave Roussy - Villejuif - France 🇫🇷 and INSERM U981
H. Jack West, MD, FAS... @JackWestMD
22K Followers 3K Following VP of Clin Development, Therapeutic Area Head, Thoracic Onc @SMMT_Tx; Founder,@CancerGRACE; fmr author/ed @UptoDate; Likes/RTs ≠ endorsement
FabriceAndre @FAndreMD
15K Followers 503 Following Head of Research Division of @GustaveRoussy , @myesmo President Elect
Christine Lovly, MD, ... @christine_lovly
8K Followers 886 Following Thoracic Medical Oncologist & Physician Scientist @VUMC. Member @AACR Board of Directors. Dog lover. Believer that kindness counts. Views = my own. @Oncoalert
Lecia Sequist, MD, MP... @LeciaSequist
10K Followers 2K Following Program Director, Cancer Early Detection & Diagnostics @MassGenBrigham @AmLungCSI #Equity #NoOneDeservesLungCancer #ScreeningSavesLives @IASLC She/her
ESMO - Eur. Oncology @myESMO
80K Followers 974 Following The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
Patrick Forde @FordePatrick
7K Followers 2K Following Lung cancer & Mesothelioma. Immunotherapy believer. 🇮🇪 🇺🇸
soria @jsoriamd
17K Followers 210 Following SVP Oncology Global Development @Amgen, Physician-Scientist, Medical Oncologist, immune and molecular target-believer, Tweets my own
IASLC @IASLC
21K Followers 2K Following The International Association for the Study of Lung Cancer is the only global organization dedicated solely to the study of lung cancer. #LCSM
Nathan A. Pennell MD,... @n8pennell
14K Followers 1K Following Thoracic oncologist, Dad, Tarheel and Steelers fan. Personal account, all opinions mine. #LCSM
Christian Rolfo @ChristianRolfo
7K Followers 2K Following Director Division of Medical Oncology. Assoc Director Early Phase Clinical Trials The James Comprehensive Cancer Center. Prof. The OSU.Liquid Biopsy T/RT my own
Alfredo Addeo MD @Alfdoc2
3K Followers 157 Following Medical Oncologist, department of oncology at the University hospital of Geneva (HUG). All opinions expressed here are my own
Charles Swanton @CharlesSwanton
16K Followers 811 Following Cancer Evolution and Genome Instability, Lung Oncologist Air Pollution and Drug Resistance Fair Weather 🚴
Elizabeth McKenna @ElizSMcKenna
18K Followers 5K Following Executive Editor of Cancer Discovery @CD_AACR, published by @AACR. @BBS_Harvard/@DanaFarber alum. Native New Yorker. Views/likes/RTs are my own. She/her
Oncogene Cancer Resea... @OncogeneCancer
953 Followers 1K Following 🔬 Research. Empowerment. Advocacy. Patients & families improving #LCSM outcomes via education, support & cutting-edge research
Mark Awad @DrMarkAwad
3K Followers 491 Following Chief, Thoracic Oncology, Memorial Sloan Kettering Cancer Center @MSKCancerCenter | Lung Cancer Immunotherapy Research | Tweets my own
Paul Romesser @DrPaulRomesser
180 Followers 194 Following Oncologist and Scientist @MSK Director of Colorectal Anal Cancer @MSK_RadOnc Husband and Father and Vizsla dad Tweets are my own...
Noura Choudhury, MD @NouraChoudhury
415 Followers 204 Following Medical oncologist , lung and head and neck cancer researcher, tea enthusiast
Rohit Thummalapalli @rohit_thum
685 Followers 555 Following GI medical oncologist @MSKCancerCenter focused on neuroendocrine and hepatobiliary cancers. Prior @oslerresidency @harvardmed @yale.
Santhosh Ambika @RenoHemonc
4K Followers 3K Following Oncologist/Hematologist- Doing my part to help onc patients. + fintwit
Fred R. Hirsch @fred_hirsch
4K Followers 59 Following I am Executive Director at the Center for Thoracic Oncology at Mount Sinai Hospital , NYC and Professor of Medicine at Icahn Medical School at Mount Sinai, NY
Claire Friedman MD @ClaireFriedma19
231 Followers 67 Following
Lukas Delasos @LukasDelasos
569 Followers 434 Following Thoracic oncologist @ClevelandClinic Taussig Cancer Center | Hem/onc graduate @ClevelandClinic | Prior chief resident @UConnIM | Proud husband and father
Klebanoff_Lab @KlebanoffLab
3K Followers 2K Following A translational research lab @MSKCancerCenter focused on the immunobiology and therapeutic potential of genetically engineered #Tcells and #TCRs. Est.2016 @NYC.
Alvaro Quintanal-Vill... @AlvaroQuintanal
550 Followers 396 Following
Guilherme Harada @HaradaGuilherme
750 Followers 709 Following Medical Oncologist at Hospital Sírio-Libanês, Brazil Former Advanced Oncology Fellow - Early Drug Development, @MSKCancerCenter
Michael Duruisseaux @MDuruisseaux
785 Followers 89 Following Thoracic Oncologist/Early Phase @CHUdeLyon Médical Director @CHUdeLyon Cancer Institute President 🇨🇵 Cooperative Oncology Group Network
RETpositive @RETpositive
1K Followers 672 Following Research, news and advocacy for caregivers and patients impacted by RET-driven cancers. Research is hope!🧬🔬
Diane Reidy-Lagunes @DianeReidyLagun
1K Followers 709 Following Tweets are my own. Podcast host. All things Duke 💙 and ❤️🇲🇽🇪🇸🇺🇸
Nuvalent @nuvalent
556 Followers 92 Following Creating #preciselytargetedtherapies for patients with cancer, designed to overcome limitations of existing therapies for clinically proven kinase targets
Emiliano Cocco @EmilianoCocco2
328 Followers 315 Following Assistant Professor of Biochemistry and Molecular Biology; University of Miami/Sylvester Cancer Center
Marcelo Corassa, MD. @MarceloCorassa
2K Followers 1K Following Husband, Father. Medical Oncologist and Researcher focused in Thoracic Oncology. Views are my own.
Gil Morgan, MD @weoncologists
16K Followers 7K Following Clinical Oncologist from Texas🇺🇸Director of @OncoAlert 🚨 Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own🌏
OncoAlert @OncoAlert
40K Followers 151 Following 🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨
Giannis Mountzios @g_mountzios
3K Followers 1K Following #MedicalOncologist MSc Transl Res Univ Paris Sud #LungCancer biology, immunotherapy, clinical trials #LCSM @myESMO faculty @iaslc live to give
Kentsis Research Grou... @KentsisResearch
4K Followers 1K Following Human biology and therapeutics group @MSKCancerCenter + @WeillCornell + @CBM_student + @TPCB_NYC + a bit of @oleg8r | https://t.co/sfdsO7td6F
NTRKers @NTRKers
890 Followers 1K Following A global, non-profit patient group, founded by patients and loved ones living with NTRK gene fusion cancer, and supported by leading clinical experts.
A. Rose Brannon @ARoseBrannon
73 Followers 42 Following Cancer scientist: focus on clinical genomics @sloan_kettering, boardgamer, and giver of free hugs. She or they.
Malinda Itchins @Mal_Itchins
947 Followers 444 Following BMedSci; MBBS; FRACP; PhD | Mumma | Medical Oncologist | Lung Cancer Researcher | Precision Medicine | Runner | Chihuahua Lover |
Nature News & Views @NatureNV
33K Followers 126 Following Expert commentary for subscribers on exciting science published in Nature and elsewhere, from astronomy to zoology. Login info at https://t.co/OrObfhBbxv
MSKCC | Parker Instit... @PICIatMSK
763 Followers 380 Following The @parkerici group at @MSKCancerCenter works to accelerate the development of breakthrough immune therapies capable of turning cancer into a curable disease.
Josiah @josiahdavidrx
197 Followers 1K Following ❤️🔥gotta step into the daylight and let it go, just let it go💛
C. Jillian Tsai, MD, ... @CJTsaiMDPhD
4K Followers 1K Following Lead, Allan & Ruth Kerbel Palliative RT/Oligomet Program (PROP) @PMcancercentre @RadMedPM @UHN. Via @MSKCancerCenter @MDAndersonNews. HN/skin/metastatic cancers
Eneda Toska Lab @EnedaToska
2K Followers 1K Following Assistant Professor at the Johns Hopkins University School of Medicine studying epigenetic regulation in breast cancer. MSKCC➡️Johns Hopkins
Sandra P D'Angelo, MD @sandrapdangelo
2K Followers 508 Following Sarcoma & Merkel cell carcinoma Medical oncologist l Immunotherapy expert l Memorial Sloan Kettering Cancer Center l Tweets are my own
Helen H Won @Helen_H_Won
129 Followers 355 Following Computational Cancer Scientist at Loxo Oncology at @Lillypad. Views are my own.
Sandra Misale @Sandra_Misale
4K Followers 1K Following Assistant professor at Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Bea Concepcion @KidneyBea_n
2K Followers 719 Following @uofcneph transplant nephrologist. Mom of 2 boys. Loves kidneys, sports, food, travel. tweets=mine 🇵🇭
Harpreet Singh, MD @harpreet_md
2K Followers 825 Following Chief Medical Officer, Precision for Medicine 🧬🥼⚕️ Former FDA Oncology Director
William Tap @WTapMD
2K Followers 662 Following Chief, #Sarcoma Medical Oncology Service, MSKCC, building an #AYA program - advice welcome. #Equity and #CulturalCompetence in #Healthcare and life.
Chul Kim @chulkimMD
3K Followers 832 Following Director of Thoracic Oncology at Georgetown University / Lung Cancer, Thymic Tumors, Phase I / #SoMeEditor @ClinicalLung | #LCSM
LudaBazhenovaMD @LudaBazhenovaMD
3K Followers 911 Following Medical oncologist specializing in lung cancer at UC San Diego. Multitasker. Love audiobooks.
Yelena Y. Janjigian M... @YJanjigianMD
9K Followers 3K Following Chief, Gastrointestinal Oncology at Memorial Sloan Kettering Cancer Center
John Chodera (he/him) @jchodera
9K Followers 7K Following Changing drug discovery one ratio of partition functions at a time. Heading up antiviral discovery for pandemics: https://t.co/uN4XpX1mjt https://t.co/YAg9PBYuBl
Jon Trent, MD, PhD @JTrentMDPhD
6K Followers 4K Following Associate Director @SylvesterCancer. Director #Sarcoma and #GIST. Telemedicine and in-person clinics are open. Tweets are my own.
Ben Drapkin @BenDrapkin
193 Followers 134 Following Thoracic oncologist at UT Southwestern Medical Center (@utswcancer), studying small cell lung cancer. Tweets are my own.Trends for United States
You might like
